Pinpointing how tumors reprogram platelets and trigger blood clots
Researchers see patient subgroups with higher clot risk
Results aid decision-making about anticoagulant therapy
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy